AGRIFORCE GROWING SYSTEMS LT (AGRI) 1.23 0 (0%)
1.23 0 (0%)
CAC009481069 - Common Stock - After market: 1.23 0 (0%)
Fundamental Rating
We assign a fundamental rating of 2 out of 10 to AGRI. AGRI was compared to 105 industry peers in the Food Products industry. Both the profitability and financial health of AGRI have multiple concerns. AGRI is valued expensive and it does not seem to be growing.
Note: AGRI has only limited data available, so a full analysis was not possible, which makes the total rating unfair.
Profitability
Profitability Rating
The Piotroski-F score of AGRI is 3.00. This is a low score and indicates issues in the health and profitability of AGRI.
VS Industry
Valuation
Valuation Rating
With a price book ratio of 1.95, AGRI is valued correctly.
Compared to an average industry price book ratio of 1.87, AGRI is valued in line with its industry peers.
AGRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AGRI. No positive earnings are expected for the next year.
VS Industry
Price/Book (1.95) VS Industry: 47% outperformed.
272.78
0.03
Growth
Growth Rating
Based on estimates for the next 5 years, AGRI will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.87% on average per year.
The earnings per share for AGRI have decreased strongly by -93.41% in the last year.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | N/A | N/A | -93.41% | 25.92% | -2.06% | 25.83% | 14.87% |
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Health
Health Rating
When comparing the Quick Ratio to an average industry Quick Ratio of 0.90, AGRI is better placed than the average industry peer to meet its short term obligations.
The Debt to Equity ratio of AGRI is way better than the industry averages. AGRI has a better rating than 86% of its industry peers.
AGRI has a Current Ratio of 1.37. This is a normal value and indicates that AGRI is financially healthy and should not expect problems in meeting its short term obligations.
AGRI has a Quick Ratio of 1.37. This is a normal value and indicates that AGRI is financially healthy and should not expect problems in meeting its short term obligations.
Compared to an average industry Current Ratio of 1.80, AGRI is worse placed to pay its short term obligations than its industry peers.
Based on the Altman-Z score of -2.68, we must say that AGRI is in the distress zone and has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.21, AGRI is in worse financial state than most of its industry peers. 88% of its industry peers have a better Altman-Z score.
AGRI has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of AGRI.
VS Industry
Debt/Equity (0) VS Industry: 86% outperformed.
53.34
0.00
Quick Ratio (1.37) VS Industry: 72% outperformed.
0.01
48.00
Current Ratio (1.37) VS Industry: 33% outperformed.
0.01
49.63
Altman-Z (-2.68) VS Industry: 12% outperformed.
-34.87
80.57
Dividend
Dividend Rating
AGRI does not give a dividend.
AGRIFORCE GROWING SYSTEMS LT1.23
NASDAQ:AGRI (2/7/2023, 7:23:02 PM)0 (0%)
| GICS Sector | Consumer Staples | ||
| GICS IndustryGroup | Food, Beverage & Tobacco | ||
| GICS Industry | Food Products | ||
| Earnings (Last) | 11-10 2022-11-10/amc | Earnings (Next) | N/A N/A |
| Inst Owners | 1.61% | Inst Owner Change | -2.19% |
| Ins Owners | 6.51% | Ins Owner Change | 0% |
| Market Cap | 19.33M | Analysts | 82.5 |
| Price Target | 5.27 (328.46%) | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Dividend Growth(5Y) | N/A | DP | N/A |
| Div Incr Years | N/A | Div Non Decr Years | N/A |
| Ex-Date | N/A | ||
| EPS beat(2) | N/A | Avg EPS beat(2) | -22.28% |
| Min EPS beat(2) | -23.46% | Max EPS beat(2) | -21.11% |
| EPS beat(4) | N/A | Avg EPS beat(4) | -19.36% |
| Min EPS beat(4) | -23.46% | Max EPS beat(4) | -13.52% |
| Revenue beat(2) | N/A | Avg Revenue beat(2) | N/A |
| Min Revenue beat(2) | N/A | Max Revenue beat(2) | N/A |
| Revenue beat(4) | N/A | Avg Revenue beat(4) | N/A |
| Min Revenue beat(4) | N/A | Max Revenue beat(4) | N/A |
| PT rev (1m) | 0% | PT rev (3m) | 0% |
| EPS NQ rev (1m) | 0% | EPS NQ rev (3m) | -91.11% |
| EPS NY rev (1m) | 0% | EPS NY rev (3m) | -21.01% |
| Revenue NQ rev (1m) | 0% | Revenue NQ rev (3m) | -85.49% |
| Revenue NY rev (1m) | 0% | Revenue NY rev (3m) | -21.82% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.95 | ||
| P/tB | 341.54 | ||
| EV/EBITDA | N/A |
| EPS(TTM) | -0.78 | EY | N/A |
| EPS(NY) | -0.69 | Fwd EY | N/A |
| FCF(TTM) | -0.74 | FCFY | N/A |
| OCF(TTM) | -0.7 | OCFY | N/A |
| SpS | N/A | BVpS | 0.63 |
| TBVpS | 0 | PEG (NY) | N/A |
| PEG (5Y) | N/A | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM | N/A | ||
| GM | N/A |
| ROICexgc(3y) | N/A | ROICexcg growth 3Y | N/A |
| ROICexcg growth 5Y | N/A | ROICexc(3y) | N/A |
| ROICexc growth 3Y | N/A | ROICexc growth 5Y | N/A |
| OM growth 3Y | N/A | OM growth 5Y | N/A |
| PM growth 3Y | N/A | PM growth 5Y | N/A |
| GM growth 3Y | N/A | GM growth 5Y | N/A |
| F-Score | 3 | Asset Turnover | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 3270.9% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | -2.68 |
| F-Score | 3 | WACC | N/A |
| ROIC/WACC | N/A | Cap/Depr(3y) | 774.35% |
| Cap/Depr(5y) | N/A | Profit Quality(3y) | N/A |
| Profit Quality(5y) | N/A | ||
| EPS 1Y | -93.41% | EPS 3Y | N/A |
| EPS 5Y | N/A | EPS growth Q2Q | -17.89% |
| EPS Next Y | 25.92% | EPS Next 2Y | -2.06% |
| EPS Next 3Y | 25.83% | EPS Next 5Y | 14.87% |
| Revenue growth 1Y | N/A | Revenue growth 3Y | N/A |
| Revenue growth 5Y | N/A | Revenue growth Q2Q | N/A |
| Revenue Next Year | N/A | Revenue Next 2Y | N/A |
| Revenue Next 3Y | N/A | Revenue Next 5Y | N/A |
| EBIT growth 1Y | -184.11% | EBIT growth 3Y | N/A |
| EBIT growth 5Y | N/A | EBIT Next Year | -112.38% |
| EBIT Next 3Y | 43.78% | EBIT Next 5Y | 66.4% |
| FCF growth 1Y | -468.72% | FCF growth 3Y | N/A |
| FCF growth 5Y | N/A | OCF growth 1Y | -439.6% |
| OCF growth 3Y | N/A | OCF growth 5Y | N/A |
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA